U S PHYSICAL THERAPY INC /NV
USPHNYSE
$73.56
↓ -0.8%Jul 17 close · end-of-day
Price
1Y↑ +2.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.1B
Enterprise Value
$1.3B
P/E
147.1
P/S
1.4
P/B
2.4
EV/EBITDA
12.7
PEG
—
FCF Yield
—
Dividend Yield
2.5%
Revenue (TTM)
$795.5M
Net Income (TTM)
$34.7M
Free Cash Flow (TTM)
—
Gross Margin
19.0%
Operating Margin
10.0%
Net Margin
4.4%
ROE
7.4%
ROIC
9.1%
Debt / Equity
0.4
Net Cash
-$176.4M
Return 1Y
+0.6%
Company profile
U.S. Physical Therapy, Inc. operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
- CEO
- Christopher J. Reading
- Sector
- Services
- Industry
- Healthcare
- Employees
- 6,140
- Headquarters
- Texas
- Website
- usph.com
Earnings
USPH Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$198.3M↑ +7.9%
Diluted EPS-$0.12↓ -115.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $423.0M | $495.0M | $553.1M | $604.8M | $671.3M | $781.0M |
| Gross profit | $94.5M | $117.2M | $112.0M | $121.5M | $123.9M | $149.7M |
| Operating income | $52.4M | $70.6M | $56.8M | $50.5M | $63.0M | $86.7M |
| Net income | $35.2M | $40.8M | $32.2M | $28.2M | $31.4M | $39.6M |
| Diluted EPS | $2.48 | $2.41 | $2.25 | $1.28 | $1.84 | $1.42 |
| Operating cash flow | $100.0M | $76.4M | $58.5M | $82.0M | $74.9M | $75.1M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | 22.3% | 23.7% | 20.3% | 20.1% | 18.5% | 19.2% |
| Operating margin | 12.4% | 14.3% | 10.3% | 8.4% | 9.4% | 11.1% |
| Net margin | 8.3% | 8.2% | 5.8% | 4.7% | 4.7% | 5.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $167.2M | $168.0M | $180.4M | $183.8M | $197.3M | $197.1M | $202.7M | $198.3M |
| Gross profit | $33.9M | $29.1M | $32.5M | $31.1M | $41.6M | $36.9M | $40.1M | $32.8M |
| Operating income | $15.6M | $12.8M | $19.7M | $19.6M | $24.9M | $25.3M | $16.8M | $12.5M |
| Net income | $7.5M | $6.6M | $9.2M | $9.9M | $12.4M | $13.1M | $4.2M | $5.0M |
| Diluted EPS | $0.47 | $0.39 | $0.52 | $0.80 | $0.58 | $0.48 | -$0.44 | -$0.12 |
| Operating cash flow | $29.0M | $22.1M | $19.4M | -$4.7M | $34.9M | $19.9M | $24.9M | $3.8M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 20.3% | 17.3% | 18.0% | 16.9% | 21.1% | 18.7% | 19.8% | 16.5% |
| Operating margin | 9.3% | 7.6% | 10.9% | 10.7% | 12.6% | 12.8% | 8.3% | 6.3% |
| Net margin | 4.5% | 3.9% | 5.1% | 5.4% | 6.3% | 6.7% | 2.0% | 2.5% |
Company news
Jul 13, 2026
Jul 2, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.